What is cytotoxic chemotherapy and when is it used for MDS?

Expert Video - What is cytotoxic chemotherapy and when is it used for MDS?

MDS experts, Dr Alan List and Dr David Sallman, provide an overview of cytotoxic chemotherapy for the treatment of myelodysplastic syndromes (MDS). This treatment uses chemotherapy to kill the abnormal cells in your bone marrow. Higher-risk MDS can potentially progress to acute myeloid leukemia (AML), so some patients with higher-risk MDS may receive the same chemotherapy treatment as AML patients.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.

Other Modules:

Managing and Treating MDS-related Anemia

Mutation-Driven Therapy in MDS

Understanding Myelodysplastic Syndromes

Understanding MDS-related Anemia

Understanding Erythropoiesis

Diagnosis of MDS

Understanding Genetic Mutations in MDS

Blood and Marrow Transplantation in MDS

Animation - Management and Treatment of MDS

Slide Show - Management and Treatment of MDS

Expert Videos

1. What are the treatment options for MDS?

2. How is lower-risk MDS treated?

3. How is higher-risk MDS treated?

4. What is supportive care for MDS?

5. Are vitamin supplements beneficial for MDS treatment?

6. What are erythropoietin-stimulating agents (ESAs)?

7. What is cytotoxic chemotherapy and when is it used for MDS?

8. What is lenalidomide and when is it used for MDS?

9. What are hypomethylating agents and when are they used for MDS?

10. How long will MDS treatment be given?

11. What is immunosuppressive therapy and when is it used for MDS?

12. What other options are there if first-line MDS treatment doesn’t work?

Patient Videos

13. David's story: How was your MDS initially treated?

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.